Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Cytomegalovirus Infection

Free Subscription Articles published in Transplant Proc Retrieve available abstracts of 25 articles: HTML format

Single Articles

May 2025
1. PAULWITZ J, Vonbrunn L, Heller K, Dieterle A, et al
   Preemptive Conversion to mTOR Inhibition to Prevent Primary Cytomegalovirus Infection in Kidney Transplantation with High-Risk Serostatus.
   Transplant Proc. 2025 May 8:S0041-1345(25)00224.
   PubMed     Abstract available
   
   
   April 2025
2. YILMAZ B, Ersan S, Mingsar G, Tanrisev M, et al
   COVID-19 Infection May Lead to Increased CMV Infection in Renal Transplant Recipients.
   Transplant Proc. 2025 Apr 29:S0041-1345(25)00207.
   PubMed     Abstract available
   
   
   March 2025
3. PANDO-CACIANO A, Mamani-Cajachagua PE, Ingunza-Tapia AA, Sanchez-Garcia GJ, et al
   Saliva Samples as a Potential Tool for the Diagnosis and Monitoring of Cytomegalovirus Reactivation in Children Undergoing Transplantation.
   Transplant Proc. 2025 Mar 10:S0041-1345(25)00103.
   PubMed     Abstract available
   
   
   February 2025
4. ANJA K, Andro K, Luciana K, Marta K, et al
   Is Cytomegalovirus (CMV) Associated With Development of Posttransplant Psychosis? A Case Report and Review of the Literature.
   Transplant Proc. 2025 Feb 26:S0041-1345(25)00089.
   PubMed     Abstract available
   
   
   
5. PAWLOWSKA A, Kwella N, Zbrzezniak-Suszczewicz J, Knysak M, et al
   First Use of Maribavir in Poland to Treat Refractory CMV Disease in a Patient After Kidney Transplantation.
   Transplant Proc. 2025 Feb 24:S0041-1345(25)00083.
   PubMed     Abstract available
   
   
   January 2025
6. SEVERO A, Gonzalez Martin J, Mateo Gomez C, Arias Mahiques J, et al
   High-risk Cytomegalovirus in Heart Transplant: How Can We Improve?
   Transplant Proc. 2025 Jan 2:S0041-1345(24)00664.
   PubMed     Abstract available
   
   
   December 2024
7. LI D, Liu C, Kang Z, Zheng Y, et al
   Imbalances of Th1/Th2 and Tc1/Tc2 are Associated With Active Cytomegalovirus Infection in Infant Liver Transplant Recipients.
   Transplant Proc. 2024 Dec 4:S0041-1345(24)00581.
   PubMed     Abstract available
   
   
   September 2024
8. WEN YC, Wang YL, Chang TY, Hsiao YW, et al
   Comparison of Cytomegalovirus Reactivation in Children After Allogeneic Hematopoietic Cell Transplantation in 2 Transplant Eras.
   Transplant Proc. 2024 Sep 3:S0041-1345(24)00469.
   PubMed     Abstract available
   
   
   August 2024
9. SCHERGER SJ, Molina KC, Palestine AG, Pecen PE, et al
   Cytomegalovirus Retinitis in the Modern Era of Solid Organ Transplantation.
   Transplant Proc. 2024 Aug 14:S0041-1345(24)00431.
   PubMed     Abstract available
   
   
   June 2024
10. GARCIA-CAMPA M, Cisneros MR, Hinojosa MD, Cauich-Carrilo J, et al
    Gastrointestinal Cytomegalovirus Infection in a Transplantation Recipient With a Negative Serum Viral Load: Case Report.
    Transplant Proc. 2024 Jun 21:S0041-1345(24)00270.
    PubMed     Abstract available
    
    
    March 2024
11. SAVAS EM, Yegin ZA, Kok MI, Karayel HT, et al
    Hypomagnesemia May Predict Better Survival and Reduced Nonrelapse Mortality in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Transplant Proc. 2024;56:386-393.
    PubMed     Abstract available
    
    
    February 2024
12. LEE JH, Lee H, Kim K, Lee SW, et al
    High-Dose Intravenous Immunoglobulin to Treat Anti-Thymocyte Globulin Induction-Related BK Virus and Cytomegalovirus Infection in Patients with ABO-Incompatible Kidney Transplantation.
    Transplant Proc. 2024 Feb 21:S0041-1345(24)00028.
    PubMed     Abstract available
    
    
    
13. KWON OK, Jeong ES, Lee KW, Choi MR, et al
    Monitoring Porcine Cytomegalovirus in Both Donors and Recipients is Crucial for Recipient's Survival in Pig-to-Cynomolgus Xenotransplantation.
    Transplant Proc. 2024 Feb 19:S0041-1345(24)00022.
    PubMed     Abstract available
    
    
    
14. GRAF M, Tuly R, Pednekar P, Wang C, et al
    Gaining Consensus Around Patient Risk Groups and Prognostic Profiles to Guide CMV Management Among Patients With Allogeneic Hematopoietic Stem Cell Transplant: Insights From a Delphi Panel With Hematopoietic Stem Cell Transplant Experts.
    Transplant Proc. 2024 Feb 17:S0041-1345(24)00077.
    PubMed     Abstract available
    
    
    
15. KLEIBOEKER H, Descourouez JL, Schulz LT, Mandelbrot DA, et al
    Resource Use and Financial Impact of Oral Step-Down Therapy for Resistant Cytomegalovirus in Solid Organ Transplant Recipients.
    Transplant Proc. 2024 Feb 13:S0041-1345(24)00061.
    PubMed     Abstract available
    
    
    
16. IDE K, Tanaka A, Tanaka Y, Nakano R, et al
    Anti-Donor T-Cell Responses Are Not Necessarily Attenuated During Cytomegalovirus Infection in Kidney Transplant Recipients.
    Transplant Proc. 2024 Feb 7:S0041-1345(24)00050.
    PubMed     Abstract available
    
    
    January 2024
17. FARKAS K, Varga M, Dinnyes I, Rem L, et al
    Low-Dose vs Standard-Dose Valganciclovir for Cytomegalovirus Prophylaxis After Kidney Transplantation: A Single-Center Retrospective Analysis.
    Transplant Proc. 2024 Jan 9:S0041-1345(23)00783.
    PubMed     Abstract available
    
    
    
18. LO TY, Wang YL, Jaing TH, Chang TY, et al
    Early Allogeneic Transplantation Favorably Influences the Outcome of Pediatric Acute Myeloid Leukemia-A Retrospective Study in a Single Center Over 2 Decades.
    Transplant Proc. 2024;56:201-210.
    PubMed     Abstract available
    
    
    September 2023
19. ROMAO EA, Yamamoto AY, Gaspar GG, Garcia TMP, et al
    Significant Increase in Cytomegalovirus (CMV) Infection in Solid Organ Transplants Associated With Increased Use of Thymoglobulin as Induction Therapy?
    Transplant Proc. 2023 Sep 29:S0041-1345(23)00564.
    PubMed     Abstract available
    
    
    
20. SAHIN AZ, Ozdemir O, Usalan O, Erdur FM, et al
    Effects of Induction Therapy on Graft Functions in Terms of Immunologic Risk.
    Transplant Proc. 2023;55:1551-1554.
    PubMed     Abstract available
    
    
    July 2023
21. SHIINA Y, Kawabe M, Suehiro Y, Katsumata H, et al
    Peripheral Blood Absolute Lymphocyte Count as a Predictor of Cytomegalovirus Infection in Kidney Transplant Recipients.
    Transplant Proc. 2023 Jul 7:S0041-1345(23)00398.
    PubMed     Abstract available
    
    
    April 2023
22. TOYA K, Tomimaru Y, Kobayashi S, Ito T, et al
    Impact of Cytomegalovirus Infection and Disease on Graft Loss After Pancreas Transplantation: A Single-Institution Study in Japan.
    Transplant Proc. 2023 Apr 29:S0041-1345(23)00223.
    PubMed     Abstract available
    
    
    
23. ISHIKAWA S, Tasaki M, Saito K, Nakagawa Y, et al
    Acquisition of Antibody Against Cytomegalovirus After Kidney Transplantation in Seronegative Recipients.
    Transplant Proc. 2023 Apr 13:S0041-1345(23)00126.
    PubMed     Abstract available
    
    
    
24. TANAKA A, Ide K, Tanaka Y, Sasaki Y, et al
    Evaluation of T-Cell Immune Status of Reduced-Dose Cyclosporine and Everolimus Combination Therapy in Kidney Transplant Patients.
    Transplant Proc. 2023 Apr 8:S0041-1345(23)00138.
    PubMed     Abstract available
    
    
    January 2023
25. HELLEMANS R, Bertels A, Wijtvliet V, Wouters K, et al
    Is Polyomavirus-Associated Nephropathy More Common in Kidney Transplant Recipients Exposed to Valganciclovir? A Retrospective Single Center Analysis.
    Transplant Proc. 2023 Jan 4:S0041-1345(22)00781.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge.